Aidapak Recalls Levothyroxine Sodium Tablets Due to Labeling Errors
Aidapak Services, LLC is recalling Levothyroxine Sodium 88 mcg tablets because they may have been mislabeled as other prescription drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Per the rubric, FDA Class II recalls involving potential mislabeling of prescription drugs, which could lead to incorrect treatment, are categorized as Severe.
Plain-English summary
Aidapak Services, LLC is voluntarily recalling Levothyroxine Sodium, Tablet, 88 mcg (NDC 00378180701) due to a labeling error. The recall was initiated because the tablets may have been mislabeled as other medications, including Nebivolol HCL, Melatonin, Isosorbide Dinitrate, and Hydrocortisone.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall covers 600-tablet units with specific pedigree codes and expiration dates ranging from May to June 2014. The FDA has classified this recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences.
Patients and healthcare providers should stop using the affected Levothyroxine Sodium tablets and contact their pharmacist or physician for a replacement. Consumers should check their medication packaging for the NDC 00378180701 and the specific pedigree codes listed in the recall notice to determine if their medication is affected.
The recalled product
- Product
- LEVOTHYROXINE SODIUM, Tablet, 88 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378180701.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- LEVOTHYROXINE SODIUM
- Tablet
- 88 mcg has the following codes: Pedigree: AD73652_10
- EXP: 5/30/2014
- Pedigree: W003047
- EXP: 6/12/2014
- Pedigree: W003476
- EXP: 6/20/2014
- Pedigree: W002967
- EXP: 6/11/2014
- Pedigree: AD42584_1
- EXP: 5/14/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02